These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Salivary antipyrine kinetics in hepatic and renal disease and in patients on anticonvulsant therapy. Harman AW; Penhall RK; Priestly BG; Frewin DB; Phillips PJ; Clarkson AR Aust N Z J Med; 1977 Aug; 7(4):385-90. PubMed ID: 270989 [TBL] [Abstract][Full Text] [Related]
3. Saliva and plasma clearance of antipyrine as reflectors of liver function. Luoma PV; Sotaniemi EA Eur J Drug Metab Pharmacokinet; 1981; 6(4):261-4. PubMed ID: 7333326 [TBL] [Abstract][Full Text] [Related]
4. A comparative study of antipyrine pharmacokinetics in saliva and plasma using a colourimetric method of antipyrine analysis. Harman AE; Priestly BG; Frewin DB Clin Exp Pharmacol Physiol; 1977; 4(6):593-6. PubMed ID: 589875 [TBL] [Abstract][Full Text] [Related]
5. Application of salivary concentration data to pharmacokinetic studies with antipyrine. Meffin PJ; Williams RL; Blaschke TF; Rowland M J Pharm Sci; 1977 Jan; 66(1):135-7. PubMed ID: 833730 [TBL] [Abstract][Full Text] [Related]
7. Elimination of antipyrine from saliva as a measure of metabolism in man. Welch RM; DeAngelis RL; Wingfield M; Farmer TW Clin Pharmacol Ther; 1975 Sep; 18(3):249-58. PubMed ID: 1164815 [TBL] [Abstract][Full Text] [Related]
8. Effects of etiocholanolone-induced fever on plasma antipyrine half-lives and metabolic clearance. Elin RJ; Vesell ES; Wolff SM Clin Pharmacol Ther; 1975 Apr; 17(4):447-57. PubMed ID: 1122686 [TBL] [Abstract][Full Text] [Related]
9. Influence of diabetes mellitus on drug metabolism in man. Daintith H; Stevenson IH; O'Malley K Int J Clin Pharmacol Biopharm; 1976 Jan; 13(1):55-8. PubMed ID: 1248919 [TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics of antipyrine in patients with graded severity of schistosomiasis. el-Raghy I; Back DJ; Osman F; Nafeh MA; Orme ML Br J Clin Pharmacol; 1985 Oct; 20(4):313-6. PubMed ID: 4074599 [TBL] [Abstract][Full Text] [Related]
11. Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time. Danhof M; van Zuilen A; Boeijinga JK; Breimer DD Eur J Clin Pharmacol; 1982; 21(5):433-41. PubMed ID: 7075648 [TBL] [Abstract][Full Text] [Related]
12. A double-blind, placebo-controlled study on the effect of vigabatrin on in vivo parameters of hepatic microsomal enzyme induction and on the kinetics of steroid oral contraceptives in healthy female volunteers. Bartoli A; Gatti G; Cipolla G; Barzaghi N; Veliz G; Fattore C; Mumford J; Perucca E Epilepsia; 1997 Jun; 38(6):702-7. PubMed ID: 9186253 [TBL] [Abstract][Full Text] [Related]
14. Impairment of human antipyrine metabolism by piroxicam. Battellino LJ; Dorronsoro de Cattoni ST; Ragagnin C Can J Physiol Pharmacol; 1990 Jun; 68(6):711-7. PubMed ID: 2372742 [TBL] [Abstract][Full Text] [Related]